Latest stories
-
Long COVID Linked to 14 Percent Higher Risk of New High Blood Pressure, Swedish Study Finds
Discover the new study linking Long COVID to a 14 percent higher risk of hypertension, and learn why cardiovascular monitoring matters now.
-
Imdelltra Plus Imfinzi Cuts Risk of Death 58% in Small Cell Lung Cancer Trial
New Phase 3 data reveals that combining Imdelltra with Imfinzi slashes death risk by 58% in patients with extensive-stage small cell lung…
-
Moderna and Merck’s Personalized Melanoma Vaccine Cuts Recurrence Risk by 42% in Late-Stage Trial
By sequencing individual tumors to target unique neoantigens, Moderna’s platform creates bespoke vaccines in nine weeks, cutting melanoma recurrence risk by 42%.
-
The Growing Financial and Regulatory Realities of Concierge Medicine Models
As concierge practices surge in popularity, patients and providers must navigate complex Medicare rules regarding membership fees and covered services.
-
European Regulators Back Breakthrough Pancreatic Cancer Drug Rasonque
The EMA has recommended approval for daraxonrasib, a daily pill that doubles survival rates for patients with metastatic pancreatic adenocarcinoma.
-
How Texas’ $6B CPRIT Outpaces NIH in Speeding Cancer Breakthroughs
The state’s aggressive funding model recruits top researchers and accelerates treatments—while federal grants face slower bureaucratic hurdles.
-
Generalized Myasthenia Gravis: Autoimmune Attack on Nerve-Muscle Junction Causes Progressive Weakness
Generalized myasthenia gravis is an autoimmune disorder where antibodies destroy acetylcholine receptors, leading to muscle weakness that worsens with activity and improves…
-
Zanidatamab’s Dual-Targeting Design Offers Alternative To Trastuzumab Deruxtecan
Zanidatamab’s unique mechanism and clinical data show promise for HER2-positive cancer treatment
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
The landmark trial published in NEJM found Dexcom G7 users achieved 0.9% greater A1C reduction versus routine care, with five more hours…
-
Cancer Researchers Face Funding Gaps and Scientific Hurdles as Personal Stories Drive Public Support
Despite rising prevention knowledge and fundraising success, scientists cite funding instability and complex tumor biology as key barriers to progress in cancer…
-
Weight-Loss Drugs Linked to Less Drinking in Study of 14,000 WeightWatchers Members
WASHINGTON, October 15 — A national survey published in JAMA Psychiatry reveals that nearly half of adults using GLP-1 receptor agonists like…
-
Google Overhauls AI Studio With a Build Tool for One-Click App Deployment
Mountain View, October 15 — Google has announced a significant update to its Google Play platform, aimed at simplifying the process for…
-
Two FDA-Approved MASH Drugs Give Patients New Options, and UCLA Health Offers a Way to Choose
LOS ANGELES, October 14 — On this date, the U.S. Food and Drug Administration granted approval to two drugs, Resmetirom and semaglutide,…
-
WHO Says 1.1 Billion Live With Obesity as Sleep, Stress and Hormones Shape Weight
Gurugram, June 19 — The World Health Organization now calls obesity one of the fastest-growing health concerns globally. That label carries weight.…
-
Diet Soft Drinks Show No Long-Term Weight or Metabolic Harm vs Water in 104-Week Trial
New York, September 30, 2026 In a significant breakthrough for millions battling weight issues, a two-year study has found that diet soft…
-
Bone Squeezing May Help Mice, Pigs Heal After Brain Injury
NEW YORK, September 27 — Scientists have found that mechanically stimulating a shinbone after a traumatic brain injury can trigger pressure-sensing bone…
-
Antidepressant Tapering Distress Is Withdrawal, Not Relapse
ROME, September 26 — The emotional distress that many people feel when they taper off or stop taking antidepressants is generally a…
-
Congenital TORCH Infections Linked to Higher Autism and Disability Risks
ATLANTA, September 21 — Children born with congenital TORCH infections are three times more likely to be diagnosed with autism spectrum disorder…
-
Abdominal Obesity Plus Vitamin D Deficiency Doubles Death Risk in Older Adults
NEW YORK, September 20 — A study of more than 5,500 people over the age of 50 has found that those with…
-
Uganda Trial: One-Fifth Yellow Fever Dose Works in Children
KAMPALA, September 13 — A clinical trial in Uganda has found that a one-fifth dose of yellow fever vaccine protected children under…
-
Rural hospital closures force pregnant women to drive farther for care
WASHINGTON, Sept. 2 — A new KFF analysis warns that in 14 states, the closure of the closest rural hospital or its…
-
Liver Supplements With Milk Thistle, Turmeric and Dandelion Root Go Mainstream, With Caveats
Milk thistle used to be something you found only in dusty health food stores, sold in brown glass bottles to people who…
-
Rebuild Savings, Avoid Loans: Financial Plan Needed Post-Overspending
New York, August 22 — A financial recovery plan has been outlined for individuals facing the challenge of overspending, according to guidance…
-
Ebola Bundibugyo Outbreak in DR Congo Reaches Eight Provinces, WHO Says
Mbandaka, August 20 — The Democratic Republic of the Congo faces a resurgent Ebola outbreak that health authorities are struggling to contain,…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992